Atorvastatin/amlodipine

Atorvastatin/amlodipine
Combination of
Amlodipine	Calcium channel blocker
Atorvastatin	Statin
Clinical data
Trade names	Caduet, Envacar
License data	US DailyMed: Caduet;
Pregnancy; category	US: X (Contraindicated) ;
Routes of; administration	By mouth
ATC code	C10BX03 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only) ; US: ℞-only ; In general: ℞ (Prescription only);
Identifiers
PubChem CID	9811759;
ChemSpider	7987512 ;
	(verify)

The drug combination atorvastatin/amlodipine (brand names Caduet in the United States, Australia, and Russia; and Envacar elsewhere) is a medication approved by the Food and Drug Administration (FDA) for the treatment of high cholesterol and high blood pressure. It is a fixed-dose combination drug containing a HMG-CoA reductase inhibitor and a calcium channel blocker being marketed by the pharmaceutical company Pfizer.[1][2]

References

"CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. February 2010. Retrieved 2010-09-25.
Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.

External links

"Amlodipine Besylate mixture with Atorvastatin Calcium". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. February 2010. Retrieved 2010-09-25.

[2] Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.